Sodium cromoglycate: spincaps or metered dose aerosol

Area of Science:

• Pediatric Pulmonology
• Respiratory Medicine
• Clinical Pharmacology

Background:

• Asthma management in children requires effective and well-tolerated inhalation therapies.
• Different formulations of inhaled medications, such as dry powder and metered dose aerosols, may have varying efficacies.
• Optimizing drug delivery and dosage is crucial for pediatric asthma control.

Purpose of the Study:

• To compare the efficacy and tolerability of sodium cromoglycate delivered via dry powder inhalation versus metered dose aerosol in asthmatic children.
• To evaluate the impact of different inhalation formulations on asthma symptom severity and bronchodilator use.
• To assess the effect of each treatment on objective lung function measures and patient weight.

Main Methods:

• An eight-week, double-blind, double-dummy, crossover trial involving 29 pediatric asthma patients.
• Comparison of sodium cromoglycate dry powder inhalation (20 mg/dose) using a Spinhaler against a metered dose aerosol (2 mg/dose).
• Assessment of symptom scores (wheeze, cough, activity limitation), bronchodilator usage, weight gain, and peak expiratory flow rates.

Main Results:

• The dry powder formulation demonstrated significantly reduced asthma symptoms, including night/day wheeze and cough, and decreased need for bronchodilator rescue medication.
• Children receiving the dry powder formulation experienced significantly greater weight gain compared to those on aerosol therapy.
• No statistically significant differences were observed in morning or evening peak flow measurements between the two treatment groups.

Conclusions:

• Dry powder inhalation of sodium cromoglycate may offer superior symptom control and potentially better systemic absorption (indicated by weight gain) in pediatric asthma compared to metered dose aerosol.
• The observed differences suggest that the dry powder formulation might be inhaled more effectively, or the aerosol dose may be insufficient for optimal therapeutic effect in this population.
• Further research is warranted to elucidate the optimal delivery method and dosage for inhaled sodium cromoglycate in children with asthma.